GlassScriptPhysician profile
Josef Tofte
NPI 1801215314
$16,408.73
in general payments reported to CMS, 2019-2025
17 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $2,168 · 2021: $1,200 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2019 | |
| Axogen | $1,616.42 | 2019-2020 | |
| Liberty Surgical INC. | $1,397.00 | 2020 | |
| Great Lakes Orthopedics | $1,200.00 | 2021 | |
| Acumed LLC | $773.85 | 2019-2020 | |
| Integra Lifesciences Corporation | $350.96 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $247.25 | 2019-2020 | |
| Stryker Corporation | $163.46 | 2025 | Variax |
| Globus Medical, INC. | $126.19 | 2019 | |
| Arthrosurface Incorporated | $125.00 | 2019 | |
| Abbvie INC. | $99.78 | 2019 | |
| Skeletal Dynamics INC | $87.50 | 2019 | |
| Depuy Synthes Sales INC. | $65.02 | 2019 | |
| Medartis INC. | $64.06 | 2019 | |
| Checkpoint Surgical, INC | $40.50 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exsomed Corporation | $37.76 | 2020 | |
| Endo Pharmaceuticals INC. | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josef Tofte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.